Cisplatin Sodium Chloride Injection

It is the first-line drug for the treatment of various solid tumors; it is the first-line treatment for SCLC or NSCLC when combined with VP-16 (EP regimen); it is the commonly used regimen for the treatment of NSCLC when combined with MMC, IFO (IMP regimen), or NVB. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. It is effective in combination with ADM, CTX, etc. for squamous cell carcinoma and transitional cell carcinoma in multiple parts, such as head and neck, cervix, esophagus and urinary system tumors; "PVB" (DDP, VLB, BLM) can treat most stage IV non-spermogenic testicular cancers, with a remission rate of 50% to 80%; in addition, this product is a radiosensitizer and is currently widely used abroad for local treatment of stage IV inoperable NSCLC

1. Cisplatin is contraindicated in patients with a history of allergy to cisplatin or other platinum-containing compounds, as well as patients with poor renal function; 2. It should be used with caution in elderly patients; 3. It is contraindicated in pregnant women and should be used with caution in lactating women.

Precautions for pregnancy and lactation: Prevented to use during pregnancy, use with caution in lactating women. Precautions for the elderly: Use with caution in elderly patients.

50ml: cisplatin 50mg and sodium chloride 450mg